A detailed history of Manning & Napier Advisors LLC transactions in Amgen Inc stock. As of the latest transaction made, Manning & Napier Advisors LLC holds 65 shares of AMGN stock, worth $19,259. This represents 0.0% of its overall portfolio holdings.

Number of Shares
65
Holding current value
$19,259
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 27, 2025

BUY
$271.18 - $309.22 $17,626 - $20,099
65 New
65 $18.3 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $159B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Manning & Napier Advisors LLC Portfolio

Follow Manning & Napier Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manning & Napier Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Manning & Napier Advisors LLC with notifications on news.